![Show Menu](styles/mobile-menu.png)
![Page Background](./../common/page-substrates/page1368.jpg)
Trials of radiotherapy after mastectomy and axillary dissection
1133 pN1-3 women in trials with systemic therapy
Locoregional recurrence
first
Any first recurrence Breast cancer mortality
Years since randomisation Years since randomisation
Years since randomisation
7.9%
11.7%
RT: Significant benefit
EBCTCG, Lancet 2014